Home › NCT05710627

Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)

Evaluation of Percutaneous Tenotomy of the Gluteus Medius and Iliotibial Band for Greater Trochanteric Pain Syndrome (GTPS): A Randomized Clinical Trial

Who can join

Ages 30 to 90 · All sexes

Inclusion Criteria:

* Aged 18-90
* People with GTPS of all different levels and etiologies confirmed with MRI or CT scan
* Ability to give informed consent forms independently
* Failed conservative medical treatment for at least 6 months

Exclusion Criteria:

* Significant mobility restrictions; people using wheelchairs
* Pregnancy
* Previous surgery to the GMed or ITB

About the study

The objective of this study is to evaluate how an ultrasound-guided percutaneous procedure, TENEX, can help people with chronic hip pain resulting from a condition called Greater Trochanteric Pain Syndrome (GTPS) and to characterize the efficacy of percutaneous tenotomy (PUT) using TENEX®, a device used for the treatment of various tendinopathies. In this study an ultrasound (US) is performed to guide the partial release of gluteus medius and minimus and Iliotibial band tendons in patients diagnosed with refractory Greater Trochanteric Pain Syndrome (GTPS) vs control. The investigator team hypothesizes that the new TENEX can improve the pain level for individuals with GTPS to help those individuals perform their activities of daily living (ADLs), e.g., walking, standing, and side-lying, as well as demonstrate less medication utilization. The study predicts that this percutaneous outpatient procedure can decrease pain, increase mobility, and decrease medication utilization.

The study team hypothesizes that PUT can improve the pain level and function for individuals suffering with GTPS. The study will assess walking, standing, and side-lying tolerance, as well as medication utilization. The investigator team predicts that this percutaneous outpatient procedure can decrease pain and medication utilization while increasing mobility.

What is being tested

• TENEX (device)

Sponsor: Montefiore Medical Center · Participants: 150 · Started: Mar 11, 2025

Contact the study team

• Tahereh Naeimi, MD · Phone: 3479778678

Official record on ClinicalTrials.gov — NCT05710627

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.